[HTML][HTML] Epidemiology, Treatment Trends, and Outcomes of Multiple Myeloma in the Middle East and Africa: A Systematic Review
M Mattar, A Bazarbachi, O Abduljalil… - Clinical Hematology …, 2024 - ncbi.nlm.nih.gov
Background Globally, multiple myeloma (MM) ranks 24 th among the most common cancers.
The Middle East and Africa are affected by an increasing trend in MM incidence, owing to …
The Middle East and Africa are affected by an increasing trend in MM incidence, owing to …
Epidemiological and immunochemical parameters of monoclonal plasma cell dyscrasias of 2121 cases in Algeria
Background Plasma cell dyscrasias (PCD) are a heterogeneous group of diseases
characterized by the expansion of monoclonal bone marrow plasma cells that produce a …
characterized by the expansion of monoclonal bone marrow plasma cells that produce a …
Clinical and paraclinical factors selection for multiple myeloma diagnosis
R GUILAL, AF BENDAHMANE… - 2019 International …, 2019 - ieeexplore.ieee.org
Multiple myeloma (Kahler's disease) is a complex blood cancer that affects the plasma cells,
which produce the antibodies to protect the human body. The diagnosis of multiple myeloma …
which produce the antibodies to protect the human body. The diagnosis of multiple myeloma …
[PDF][PDF] Evaluation de la toxicité du Bortézomib chez les patients atteints d'un myélome multiple au CHU Tlemcen
SM Amine, L Jury - dspace1.univ-tlemcen.dz
Le myélome multiple ou Maladie de Kahler est une hémopathie maligne incurable
caractérisée par la prolifération clonale de plasmocytes tumoraux envahissant la moelle …
caractérisée par la prolifération clonale de plasmocytes tumoraux envahissant la moelle …
[引用][C] Impact pronostique de l'insuffisance rénale chez les patients atteints de myélome multiple de novo à l'ère des nouvelles molécules
H Ahmidatou, N Belarbi Boudjerra - 2021
[引用][C] Les paramètres sériques et immunologiques chez des patients atteints d'un myélome multiple
N Zeraigui, H Heriche - 2021